Empirical Functional PCA for 3D Image Feature Extraction Through Fractal Sampling.
| dc.centro | E.T.S.I. Telecomunicación | es_ES |
| dc.contributor.author | Ortiz-García, Andrés | |
| dc.contributor.author | Munilla-Fajardo, Jorge | |
| dc.contributor.author | Martínez-Murcia, Francisco Jesús | |
| dc.contributor.author | Górriz-Sáez, Juan Manuel | |
| dc.contributor.author | Ramírez-Aguilar, Francisco Javier | |
| dc.date.accessioned | 2023-11-22T08:07:25Z | |
| dc.date.available | 2023-11-22T08:07:25Z | |
| dc.date.issued | 2018-10-16 | |
| dc.departamento | Ingeniería de Comunicaciones | |
| dc.description.abstract | Medical image classification is currently a challenging task that can be used to aid the diagnosis of different brain diseases. Thus, exploratory and discriminative analysis techniques aiming to obtain representative features from the images play a decisive role in the design of effective Computer Aided Diagnosis (CAD) systems, which is especially important in the early diagnosis of dementia. In this work, we present a technique that allows using specific time series analysis techniques with 3D images. This is achieved by sampling the image using a fractal-based method which preserves the spatial relationship among voxels. In addition, a method called Empirical functional PCA (EfPCA) is presented, which combines Empirical Mode Decomposition (EMD) with functional PCA to express an image in the space spanned by a basis of empirical functions, instead of using components computed by a predefined basis as in Fourier or Wavelet analysis. The devised technique has been used to classify images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and the Parkinson Progression Markers Initiative (PPMI), achieving accuracies up to 93% and 92% differential diagnosis tasks (AD versus controls and PD versus Controls, respectively). The results obtained validate the method, proving that the information retrieved by our methodology is significantly linked to the diseases. | es_ES |
| dc.description.sponsorship | This work was partly supported by the MINECO/ FEDER under TEC2015-64718-R and PSI2015- 65848-R projects and the Consejer´ıa de Innovaci´on, Ciencia y Empresa (Junta de Andaluc´ıa, Spain) under the Excellence Project P11-TIC-7103 as well as the Salvador deMadariaga Mobility Grants 2017. Data collection and sharing for this project was funded by the ADNI (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Depart ment of Defense award number W81XWH-12-2- 0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contribu tions from the following: AbbVie, Alzheimer’s Asso ciation; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol Myer Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Ho mann-La Roche Ltd and its ali ated company Genentech, Inc.; Fujirebio; GE Health care; IXICO Ltd.; Janssen Alzheimer Immunother apy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; P zer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clin ical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coor dinated by the Alzheimer’s Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern Cali fornia. PPMI a public-private partnership is funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners, including [list the full names of all of the PPMI funding partners found at www.ppmi-info.org/fundingpartners]. | es_ES |
| dc.identifier.citation | Ortiz, Andrés & Munilla, Jorge & Martínez-Murcia, Francisco & Gorriz, Juan & Ramírez, Javier. (2018). Empirical Functional PCA for 3D Image Feature Extraction Through Fractal Sampling. International Journal of Neural Systems. 29. 10.1142/S0129065718500405. | es_ES |
| dc.identifier.doi | 10.1142/S0129065718500405 | |
| dc.identifier.uri | https://hdl.handle.net/10630/28104 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | World Scientific | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Alzheimer, Enfermedad de | es_ES |
| dc.subject | Parkinson, Enfermedad de | es_ES |
| dc.subject | Diagnóstico por imagen | es_ES |
| dc.subject.other | Hilbert curve | es_ES |
| dc.subject.other | EEMD | es_ES |
| dc.subject.other | Empirical functional PCA | es_ES |
| dc.subject.other | SVM | es_ES |
| dc.subject.other | PET | es_ES |
| dc.subject.other | Alzheimer’s disease | es_ES |
| dc.subject.other | Parkinson's disease | es_ES |
| dc.title | Empirical Functional PCA for 3D Image Feature Extraction Through Fractal Sampling. | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | AM | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 5d9e81fc-5f53-42ea-82c8-809b9defd772 | |
| relation.isAuthorOfPublication | 053de28f-d29d-4745-9581-111e59a126c8 | |
| relation.isAuthorOfPublication | ade1cc89-f5ec-4293-927a-ab131b0e1fc8 | |
| relation.isAuthorOfPublication.latestForDiscovery | 5d9e81fc-5f53-42ea-82c8-809b9defd772 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- IJNS 1850040 1st Prf.pdf
- Size:
- 2.07 MB
- Format:
- Adobe Portable Document Format
- Description:

